Biosimilars: innovation from sustainability

Reports on biosimilar medicines

This document has been coordinated and written by Professor Fernando de Mora, Professor of Pharmacology at the Autonomous University of Barcelona. In addition, the document has been revised and enriched with the contributions of a group of experts made up (in alphabetical order of the first surname) by:

  • Marie Elise Beydon, R&D CMC Manager MABXIENCE
  • Maria Dolores Canela, Associate Director Medical Affairs ORGANON
  • Rosario García de Vicuña, Head of the Rheumatology Service at La Princesa University Hospital, Madrid
  • José Luis Guallar, SANOFI Medical Director
  • Rafael Martínez, SANDOZ Medical Director
  • Fernando Méndez, Director, Spain Policy and Public Affairs PFIZER
  • Vicente Merino, FEA Hospital Pharmacy. Virgen de la Macarena University Hospital, Seville.
  • Sofía Somoza, Director Regulatory Affairs ORGANON

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.